Generally, anemia is one of the challenging manifestations in the management of MF, related to multifactorial and not fully understood mechanisms, such as increase in bone marrow fibrosis, higher hepcidin levels, ineffective erythropoiesis, and splenomegaly [51]. Here, HAMP is linked to anemia.